Retraction Note: Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific ScFv antibody and class A scavenger receptor activator show therapeutic potentials for alzheimer's disease. [PDF]
Liu XG +8 more
europepmc +1 more source
Structure-guided design of antibody CDRs to reduce their reactivity to treatment-emergent anti-drug antibodies. [PDF]
Johansson MU +13 more
europepmc +1 more source
Engineered extracellular vesicles-mediated curcumin delivery in brain microenvironment modulating lysosomes, mitochondria, and microglia reprogram for parkinson's disease therapy. [PDF]
Shie MY +13 more
europepmc +1 more source
Deciphering Protein Corona by scFv-Based Affinity Chromatography
It remains challenging to precisely decipher the structural and functional characteristics of protein coronas. To overcome the drawbacks frequently occurring in the traditional separation methods, an anti-PEG single-chain variable fragment (PEG-scFv ...
Cheng Li, Xiaoli Wei, Tianlei Ying
exaly +5 more sources
Related searches:
The most common recombinant antibody format is the single chain fragment variable (scFv) which it contains the complete antigen-binding domains of an intact antibody. ScFv fragments have found vast medical and non-medical applications. Several approaches have been employed to increase the affinity, avidity and structural stability related to these ...
Peyman Bemani +2 more
semanticscholar +3 more sources
Rapid, Point-of-Care scFv-SERS Assay for Femtogram Level Detection of SARS-CoV-2
Rapid, sensitive, on-site identification of SARS-CoV-2 infections is an important tool in the control and management of COVID-19. We have developed a surface-enhanced Raman scattering (SERS) immunoassay for highly sensitive detection of SARS-CoV-2 ...
Patrick Alfred Johnson, J Gerard Wall
exaly +2 more sources
Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy
Chan Liao, Yong-Min Tang, Chun Zhou
exaly +2 more sources
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
The efficacy of chimeric antigen receptor (CAR) T cell therapy against poorly responding tumors can be enhanced by administering the cells in combination with immune checkpoint blockade inhibitors.
Sarwish Rafiq +2 more
exaly +2 more sources
T cell–bispecific antibody antitumor function is maximized through optimal interdomain spacing and dual cis-configurations. The specifics of bispecifics T cell–bispecific antibodies, which are designed to bring T cells together with tumor cells and ...
Brian H Santich +2 more
exaly +2 more sources

